Appendiceal Goblet Cell Carcinoma: Role of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Roy P (2010) Goblet cell carcinoid tumors of the appendix: an overview. World J Gastrointest Oncol 2:251. https://doi.org/10.4251/wjgo.v2.i6.251
Huang D, Ren F, Ni S et al (2019) Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity. Cancer Cell Int 19:1–13. https://doi.org/10.1186/s12935-019-1031-7
McCusker ME, Coté TR, Clegg LX, Sobin LH (2002) Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973–1998. Cancer 94:3307–3312. https://doi.org/10.1002/cncr.10589
Gui X, Qin L, Gao ZH et al (2011) Goblet cell carcinoids at extraappendiceal locations of gastrointestinal tract: an underrecognized diagnostic pitfall. J Surg Oncol 103:790–795. https://doi.org/10.1002/jso.21863
Shibuya H, Hijioka S, Mizuno N et al (2018) A rare case of ampullary goblet cell carcinoid. Intern Med 57:2489–2496. https://doi.org/10.2169/internalmedicine.0516-17
Gallegos NC, Milroy C, Linehan IP, Boulos PB (1992) Crypt cell carcinoma of the appendix. Eur J Surg Oncol 18:386–387
Pahlavan PS, Kanthan R (2005). Goblet cell carcinoid of the appendix. https://doi.org/10.1186/1477-7819-3
Lee KS, Tang LH, Shia J et al (2013) Goblet cell carcinoid neoplasm of the appendix: clinical and CT features. Eur J Radiol 82:85–89. https://doi.org/10.1016/j.ejrad.2012.05.038
Pickhardt PJ, Levy AD, Rohrmann CA, Kende AI (2003) Primary neoplasms of the appendix: radiologic spectrum of disease with pathologic correlation. Radiographics 23:645–662. https://doi.org/10.1148/RG.233025134
Zhang K, Meyerson C, Kassardjian A et al (2019) Goblet cell carcinoid/carcinoma: an update. Adv Anat Pathol 26:75–83. https://doi.org/10.1097/PAP.0000000000000222
Mo S, Zhou Z, Ying Z et al (2019) Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study. Int J Colorectal Dis 34:1915–1924. https://doi.org/10.1007/s00384-019-03387-y
Tang LH, Shia J, Soslow RA, et al (2008) Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix
Turaga KK, Pappas SG, Gamblin TC (2012) Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol 19:1379–1385. https://doi.org/10.1245/S10434-012-2238-1
Reid MD, Basturk O, Shaib WL et al (2016) Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases. Mod Pathol 29:1243–1253. https://doi.org/10.1038/MODPATHOL.2016.105
Pham TH, Wolff B, Abraham SC, Drelichman E (2006) Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience. Ann Surg Oncol 13:370–376. https://doi.org/10.1245/ASO.2006.02.016
Govaerts K, Lurvink RJ, de Hingh IHJT et al (2021) Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol 47:11–35. https://doi.org/10.1016/J.EJSO.2020.02.012
Pape UF, Perren A, Niederle B et al (2012) ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology 95:135–156. https://doi.org/10.1159/000335629
Lee WS, Choi ST, Lee JN et al (2011) A retrospective clinicopathological analysis of appendiceal tumors from 3,744 appendectomies: a single-institution study. Int J Colorectal Dis 26:617–621. https://doi.org/10.1007/S00384-010-1124-1
Murphy EMA, Farquharson SM, Moran BJ (2006) Management of an unexpected appendiceal neoplasm. Br J Surg 93:783–792. https://doi.org/10.1002/BJS.5385
Boudreaux JP, Klimstra DS, Hassan MM et al (2010) The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas 39:753–766. https://doi.org/10.1097/MPA.0b013e3181ebb2a5
Madsen AH, Ladekarl M, Villadsen GE et al (2018) Effects of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of goblet cell carcinoma: a prospective cohort study. Ann Surg Oncol 25:422–430. https://doi.org/10.1245/S10434-017-6272-X
McConnell YJ, Mack LA, Gui X et al (2014) Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix. Ann Surg Oncol 21:1975–1982. https://doi.org/10.1245/S10434-013-3469-5
Mahteme H, Sugarbaker PH (2004) Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg 91:1168–1173. https://doi.org/10.1002/BJS.4609
Hsin-Hsien Y, Yonemura Y, Mao-Chih H et al (2017) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center. Cancer Manag Res 9:513–523. https://doi.org/10.2147/CMAR.S147227
Shyu S, Choudry H, Hall L et al (2020) Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitoneal chemotherapy. Histopathology 77:798–809. https://doi.org/10.1111/his.14189
Radomski M, Pai RK, Shuai Y et al (2016) Curative surgical resection as a component of multimodality therapy for peritoneal metastases from goblet cell carcinoids. Ann Surg Oncol 23:4338–4343. https://doi.org/10.1245/S10434-016-5412-Z
Taggart MW, Abraham SC, Overman MJ et al (2015) Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis. Arch Pathol Lab Med 139:782–790. https://doi.org/10.5858/ARPA.2013-0047-OA
Yan TD, Brun EA, Sugarbaker PH discordant histology of primary appendiceal adenocarcinoid neoplasms with peritoneal dissemination. https://doi.org/10.1245/s10434-007-9754-4
Shenoy S (2016) Goblet cell carcinoids of the appendix: tumor biology, mutations and management strategies. World J Gastrointest Surg 8:660–669. https://doi.org/10.4240/wjgs.v8.i10.660
Madani A, van der Bilt JDW, Consten ECJ, et al Perforation in appendiceal well-differentiated carcinoid and goblet cell tumors: impact on prognosis? A systematic review. https://doi.org/10.1245/s10434-014-4023-9
Nagtegaal ID, Odze RD, Klimstra D et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182–188. https://doi.org/10.1111/HIS.13975
van der Speeten K, Lemoine L, Sugarbaker P (2017) Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice. Pleura Peritoneum 2:63–72. https://doi.org/10.1515/PP-2017-0003/ASSET/GRAPHIC/PP-2017-0003_FIGURE1.JPG
van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH (2010) Pharmacology of perioperative 5-fluorouracil. J Surg Oncol 102:730–735. https://doi.org/10.1002/jso.21702
Elias D, Lefevre JH, Chevalier J et al (2008) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–685. https://doi.org/10.1200/JCO.2008.19.7160
Muggia FM (2009) Heidelberger symposium on the 50th anniversary of fluoropyrimidines. https://doi.org/10.1158/1535-7163.MCT-08-0732
Jiang Y, Long H, Li T et al (2012) Schistosomiasis may contribute to goblet cell carcinoid of the appendix. J Parasitol 98:565–568. https://doi.org/10.1645/JP-GE-2865.1
Bell PD, Pai RK (2022) Goblet cell adenocarcinoma of the appendix: an update and practical approach to diagnosis and grading. Hum Pathol. https://doi.org/10.1016/J.HUMPATH.2022.06.002
Arai H, Baca Y, Battaglin F et al (2020) Molecular characterization of appendiceal goblet cell carcinoid. Mol Cancer Ther 19:2634–2640. https://doi.org/10.1158/1535-7163.MCT-20-0318
Johncilla M, Stachler M, Misdraji J et al (2018) Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas. Mod Pathol 31:989–996. https://doi.org/10.1038/S41379-018-0003-0
Jesinghaus M, Konukiewitz B, Foersch S et al (2018) Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix. Mod Pathol 31:829–839. https://doi.org/10.1038/MODPATHOL.2017.184
Lee LH, McConnell YJ, Tsang E et al (2015) Simplified 2-tier histologic grading system accurately predicts outcomes in goblet cell carcinoid of the appendix. Hum Pathol 46:1881–1889. https://doi.org/10.1016/J.HUMPATH.2015.08.005
Rossi RE, Luong TV, Caplin ME et al (2015) Goblet cell appendiceal tumors–management dilemmas and long-term outcomes. Surg Oncol 24:47–53. https://doi.org/10.1016/J.SURONC.2015.01.001
Holt N, Grønbæk H (2013) Goblet cell carcinoids of the appendix. ScientificWorldJournal 2013:. https://doi.org/10.1155/2013/543696
Dromain C, de Baere T, Lumbroso J et al (2005) Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 23:70–78. https://doi.org/10.1200/JCO.2005.01.013
Maggard MA, O’Connell JB, Ko CY (2004) Updated population-based review of carcinoid tumors. Ann Surg 240:117–122. https://doi.org/10.1097/01.SLA.0000129342.67174.67
Burke AP, Sobin LH, Federspiel BH et al (1990) Goblet cell carcinoids and related tumors of the vermiform appendix. Am J Clin Pathol 94:27–35. https://doi.org/10.1093/AJCP/94.1.27
Patel GS, Karapetis CS (2013) Personalized treatment for advanced colorectal cancer: KRAS and beyond. Cancer Manag Res 5:387–400. https://doi.org/10.2147/CMAR.S35025
Liu DSH, Read M, Cullinane C et al (2015) APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma. Gut 64:1506–1516. https://doi.org/10.1136/GUTJNL-2015-309770
Lehmann S, Bykov VJN, Ali D et al (2012) Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer. J Clin Oncol 30:3633–3639. https://doi.org/10.1200/JCO.2011.40.7783
Wang HL, Dhall D (2009) Goblet or signet ring cells: that is the question. Adv Anat Pathol 16:247–254. https://doi.org/10.1097/PAP.0B013E3181A9D49A
Yozu M, Johncilla ME, Srivastava A et al (2018) Histologic and outcome study supports reclassifying appendiceal goblet cell carcinoids as goblet cell adenocarcinomas, and grading and staging similarly to colonic adenocarcinomas. Am J Surg Pathol 42:898–910. https://doi.org/10.1097/PAS.0000000000001056
Varisco B, Mcalvin B, Dias J, Franga D (2022) Adenocarcinoid of the appendix: is right hemicolectomy necessary? A meta-analysis of retrospective chart reviews. https://doi-org.kuleuven.e-bronnen.be/101177/000313480407000706 70:593–599. https://doi.org/10.1177/000313480407000706
Bucher P, Gervaz P, Ris F et al (2005) Surgical treatment of appendiceal adenocarcinoid (goblet cell carcinoid). World J Surg 29:1436–1439. https://doi.org/10.1007/S00268-005-7958-Y
Schuitevoerder D, Plana A, Izquierdo FJ et al (2020) The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Ann Surg Oncol 27:1753–1760. https://doi.org/10.1245/S10434-020-08316-W
Fields AC, Lu P, Enzinger A et al (2019) Treatment patterns and outcomes in goblet cell carcinoid tumors of the appendix. J Surg Oncol 120:1096. https://doi.org/10.1002/jso.25723
Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374. https://doi.org/10.1007/978-1-4613-1247-5_23
Randle RW, Griffith KF, Fino NF et al (2015) Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res 196:229–234. https://doi.org/10.1016/J.JSS.2015.03.051
Lamarca A, Nonaka D, Lopez Escola C et al (2016) Appendiceal goblet cell carcinoids: management considerations from a reference peritoneal tumour service centre and ENETS centre of excellence. Neuroendocrinology 103:500–517. https://doi.org/10.1159/000440725
Klaver G, Wisselink CEL, Punt DD et al (2019) Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) COLOPEC Citation for published version (APA): COLOPEC Collaborators Grp Articles Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. 761. https://doi.org/10.1016/S2468-1253(19)30239-0
Arjona-Sanchez A, Cano-Osuna MT, Gutierrez A et al (2022) 314O Adjuvant hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): a randomized phase III study. Ann Oncol 33:S680. https://doi.org/10.1016/j.annonc.2022.07.452
Dindo D, Demartines N, Clavien P-A, Clavien P-A (2004) Classification of surgical complications a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery • 240. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Piso P, Nedelcut SD, Rau B et al (2019) Morbidity and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: data from the DGAV StuDoQ registry with 2149 consecutive patients. Ann Surg Oncol 26:148–154. https://doi.org/10.1245/S10434-018-6992-6